Pediatric Nephrology

, Volume 21, Issue 11, pp 1653–1660

WT1 and glomerular diseases

Review

Abstract

The WT1 gene encodes a zinc finger transcription factor involved in kidney and gonadal development and, when mutated, in the occurrence of kidney tumor and glomerular diseases. Patients with Denys-Drash syndrome present with early nephrotic syndrome with diffuse mesangial sclerosis progressing rapidly to end-stage renal failure, male pseudohermaphroditism, and Wilms' tumor. Incomplete forms of the syndrome have been described. Germline WT1 missense mutations located in exons 8 or 9 coding for zinc fingers 2 or 3 have been detected in nearly all patients with Denys-Drash syndrome and in some patients with isolated diffuse mesangial sclerosis. Patients with Frasier syndrome present with normal female external genitalia, streak gonads, XY karyotype and progressive nephropathy with proteinuria and nephrotic syndrome with focal and segmental glomerular sclerosis progressing to end-stage renal disease in adolescence or young adulthood. They frequently develop gonadoblastoma. Germline intronic mutations leading to the loss of the +KTS isoforms have been observed in all patients with Frasier syndrome. The same mutations have been observed in genetically female patients with isolated FSGS. Transmission of the mutation is possible. Frasier mutations have also been reported in children with Denys-Drash syndrome.

Keywords

WT1 gene Denys-Drash syndrome Frasier syndrome Diffuse mesangial sclerosis FSGS Wilms’ tumor Glomerular disease 

References

  1. 1.
    Call KM, Glaser T, Ito CY, Buckler AL, Pelletier J, Haber DA, Rose EA, Krai A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 60:509–520PubMedCrossRefGoogle Scholar
  2. 2.
    Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990). Homozygous deletion in Wilms’ tumors of a zinc-finger gene identified by chromosome jumping. Nature 343:774–778PubMedCrossRefGoogle Scholar
  3. 3.
    Ricciardi VM, Sujansky F, Smith AC, Francke U (1978) Chromosomal imbalance in the aniridia-Wilms’ tumor association: 11p interstitial deletion. Pediatrics 61:604–610Google Scholar
  4. 4.
    Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF (1991) Evidence for WT1 as a Wilms’ tumor (WT) gene: intragenic deletion in bilateral Wilms’ tumor. Am J Hum Genet 48:997–1003PubMedGoogle Scholar
  5. 5.
    Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1991) Isolation, characterization, and expression of the murine Wilms’ tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707–1712PubMedGoogle Scholar
  6. 6.
    Coppes MJ, Campbell CE, Williams BRG (1993) The role of WT1 on Wilms’ tumorigenesis. FASEB J 7:886–893PubMedGoogle Scholar
  7. 7.
    Gessler M, Konig A, Bruns GAP (1992) The genomic organization and expression of the WTl gene. Genomics 12:807–813PubMedCrossRefGoogle Scholar
  8. 8.
    Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms’ tumor gene WT1. Proc Natl Acad Sci USA 88:9618–9622PubMedCrossRefGoogle Scholar
  9. 9.
    Rauscher FJ III (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 270:896–903Google Scholar
  10. 10.
    Wang ZY, Qiu QQ, Deuel TF (1993) The Wilms’ tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem 268:9172–9175PubMedGoogle Scholar
  11. 11.
    Moffett P, Bruening W, Nakagama H, Bardeesy N, Housman DE, Pelletier J (1995) Antagonism of WT1 activity by protein self-association. Proc Natl Acad Sci USA 92:11105–11109PubMedCrossRefGoogle Scholar
  12. 12.
    Bruening W, Pelletier J (1996) A non-AUG translational initiation event generates novel WT1 protein isoforms. J Biol Chem 15:8646–8654Google Scholar
  13. 13.
    Sharma PM, Bowman M, Madden SL, Rauscher FJ, Sukumar SL (1994) RNA editing in the Wilms’ tumor susceptibility gene, WT1. Genes Dev 8:720–731PubMedCrossRefGoogle Scholar
  14. 14.
    Drummond IA, Rupprecht HD, Rower-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher F Jr, Sikhatme VP (1994) DNA recognition by splicing variants of the Wilms tumor suppressor WT1. Mol Cell Biol 14:3800–3809PubMedGoogle Scholar
  15. 15.
    Hewitt SM, Fraizer GC, Wu YJ, Rauscher FJ III, Saunders GF (1996) Differential function of Wilms’ tumor gene WTl splice isoforms in transcriptional regulation. J Biol Chem 271:8588–8592PubMedCrossRefGoogle Scholar
  16. 16.
    Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Ce1l 81:391–401Google Scholar
  17. 17.
    Reddy JC, Licht JD (1996) The WTl Wilms’ tumor suppressor gene: how much do we really know? Biochim Biophys Acta 1287:1–28PubMedGoogle Scholar
  18. 18.
    Denys P, Malvaux P, Berghe HVD, Tanghe W, Proesmans W (1967) Association d’un syndrome anatomopathologique de pseudohermaphrodisme masculin, d’une tumeur de Wilms, d’une nephropathie parenchymateuse et d’un mosaicisme XX/XY. Arch Fr Pediatr 24:729–739PubMedGoogle Scholar
  19. 19.
    Drash A, Sherman F, Hartmann W, Blizzard R (1970) A syndrome of pseudohermaphroditism, Wilms’ tumour, hypertension, and degenerative renal disease. J Pediatr 76:585–593PubMedCrossRefGoogle Scholar
  20. 20.
    Mueller RF (1994) The Denys-Drash syndrome. J Med Genet 31:471–477PubMedGoogle Scholar
  21. 21.
    Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, Barratt TM (1990) Clinicopathologic review of twelve children with nephropathy, Wilm’s tumour, and genital abnormalities (Drash syndrome). J Pediatr 117:717–725PubMedCrossRefGoogle Scholar
  22. 22.
    Habib R, Gubler MC, Antignac C, Gagnadoux MF (1993) Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol 22:43–56Google Scholar
  23. 23.
    Maalouf EF, Ferguson J, van Heyningen V, Modi N (1998) In utero nephropathy, Denys-Drash syndrome and Potter phenotype. Pediatr Nephrol 12:449–451PubMedCrossRefGoogle Scholar
  24. 24.
    Hu M, Zhang GY, Arbuckle S, Graf N, Shun A, Silink M, Lewis D, Alexander SI (2004) Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene. Nephrol Dial Transplant 19:223–226PubMedCrossRefGoogle Scholar
  25. 25.
    Jeanpierre C, Denamur E, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations in patients with isolated diffuse mesangial sclerosis (IDMS) and analysis of genotype-phenotype correlations using a computerized mutation database. Am J Hum Genet 62:824–833PubMedCrossRefGoogle Scholar
  26. 26.
    Devriendt K, Deloof E, Moerman P, Legius E, Vanhole C, de Zegher F, Proesmans W, Devlieger H (1995) Diaphragmatic hernia in Denys-Drash syndrome. Am J Med Genet 57:97–101PubMedCrossRefGoogle Scholar
  27. 27.
    Habib R, Loirat C, Gubler M-C, Niaudet P, Bensman A, Levy M, Broyer M (1985) The nephropathy associated with male pseudohermaphroditism and Wilms’ tumour (Drash syndrome): a distinctive glomerular lesion—report of 10 cases. Clin Nephrol 24:269–278PubMedGoogle Scholar
  28. 28.
    Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209–225PubMedCrossRefGoogle Scholar
  29. 29.
    Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447PubMedCrossRefGoogle Scholar
  30. 30.
    Jeanpierre C, Béroud C, Niaudet P, Junien C (1998) Software and database for the analysis of mutations in the human WT1 gene. Nucl Acids Res 26:273–277CrossRefGoogle Scholar
  31. 31.
    Schumacher V, Schärer K, Wühl E, Altrogge H, Bonzel KE, Guschmann M, Neuhaus TJ, Pollastro RM, Kuwertz-Broking E, Bulla M, Tondera AM, Mundel P, Helmchen U, Waldherr R, Weirich A, Royer-Pokora B (1998) Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 53:1594–1600PubMedCrossRefGoogle Scholar
  32. 32.
    Koziell AB, Grundy R, Barratt TM, Scambler P (1999) Evidence for genetic heterogeneity of nephropathic phenotypes associated with Denys-Drash and Frasier syndromes. Am J Hum Genet 64:1778–1781PubMedCrossRefGoogle Scholar
  33. 33.
    Little S, Hanks S, King-Underwood L, Picton S, Cullinane C, Rapley E, Rahman N, Pritchard-Jones K (2005) A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Pediatr Nephrol 20:81–85PubMedCrossRefGoogle Scholar
  34. 34.
    Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC (1999) WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 54:181–192Google Scholar
  35. 35.
    Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H (1993) Deregulation of PAX-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65–67PubMedCrossRefGoogle Scholar
  36. 36.
    Patek CE, Little MH, Fleming S, Miles C, Charlieu JP, Clarke AR, Miyagawa K, Christie S, Doig J, Harrison DJ, Porteous DJ, Brookes AJ, Hooper ML, Hastie ND (1999) A zinc finger truncation of murine WTl results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci USA 96:2931–2936PubMedCrossRefGoogle Scholar
  37. 37.
    Ohta S, Ozawa T, Izumino K, Sakuragawa N, Fuse H (2000) A novel missense mutation of the WTl gene causing Denys-Drash syndrome with exceptionally mild renal manifestations. J Urol 163:1857–1858PubMedCrossRefGoogle Scholar
  38. 38.
    Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, Yamada M (1999) Exon 9 mutations in the WTl gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14:466–470PubMedCrossRefGoogle Scholar
  39. 39.
    Coppes MJ, Liefers G, Higuchi M, Zinn A, Balfe J, Williams B (1992) Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 52:6125–6128PubMedGoogle Scholar
  40. 40.
    Diller L, Ghahremani M, Morgan J, Grundy P, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP (1998) Constitutional WT1 mutations in Wilms’ tumor patients. J Clin Oncol 16:3634–3640PubMedGoogle Scholar
  41. 41.
    Kaplinsky C, Ghahremani M, Frishberg Y, Rechavi G, Pelletier J (1996) Familial Wilms’ tumor associated with a WTl zinc finger mutation. Genomics 38:451–453PubMedCrossRefGoogle Scholar
  42. 42.
    Kohler B, Schumacher V, Schulte-Overberg U, Biewald W, Lennert T, l’Allemand D, Royer-Pokora B, Gruters A (1999) Bilateral Wilms tumor in a boy with severe hypospadias and cryptorchidism due to a heterozygous mutation in the WTl gene. Pediatr Res 45:187–190PubMedCrossRefGoogle Scholar
  43. 43.
    Gubler MC, Yang Y, Jeanpierre C, Barbaux S, Niaudet P (1999) WT1, renal development, and glomerulopathies. Adv Nephrol Necker Hosp 29:299–315PubMedGoogle Scholar
  44. 44.
    Ito S, Takata A, Hataya H, Ikeda M, Kikuchi H, Hata J, Honda M (2001) Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene. J Pediatr 138:425–427PubMedCrossRefGoogle Scholar
  45. 45.
    Hahn H, Cho YM, Park YS, You HW, Cheong HI (2006) Two cases of isolated diffuse mesangial sclerosis with WT1 mutations. J Korean Med Sci 21:160–164PubMedCrossRefGoogle Scholar
  46. 46.
    Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13:2625–2632PubMedCrossRefGoogle Scholar
  47. 47.
    Frasier SD, Bashore RA, Mosier HD (1964) Gonadoblastoma associated with pure gonadal dysgenesis in monozygotic twins. J Pediatr 64:740–745PubMedCrossRefGoogle Scholar
  48. 48.
    Moorthy AV, Chesney RW, Lubinsky M (1987) Chronic renal failure and XY gonadal dysgenesis: “Frasier” syndrome—a commentary on reported cases. Am J Med Genet 3:297–302CrossRefGoogle Scholar
  49. 49.
    Barbaux S, Niaudet P, Gubler MC, Grunfeld J-P, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467–470PubMedCrossRefGoogle Scholar
  50. 50.
    Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H, Kurosawa Y, Honda M, Kamiyama Y, Hata J (1998) Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J Med Genet 35:45–48PubMedCrossRefGoogle Scholar
  51. 51.
    Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1+/-KTS splice isoforms. Hum Mol Genet 7:709–714PubMedCrossRefGoogle Scholar
  52. 52.
    Barbosa AS, Hadjiathanasiou CG, Theodoridis C, Papathanasiou A, Tar A, Merksz M, Gyorvari B, Sultan C, Dumas R, Jaubert F, Niaudet P, Moreira-Filho CA, Cotinot C, Fellous M (1999) The same mutation affecting the splicing of WT1 gene is present in Frasier syndrome patients with or without Wilms’ tumor. Hum Mutat 13:146–153PubMedCrossRefGoogle Scholar
  53. 53.
    Okuhara K, Tajima S, Nakae J, Sasaki S, Tochimaru H, Abe S, Fujieda K (1999) A Japanese case with Frasier syndrome caused by the splice junction mutation of WT1 gene. Endocr J 46:639–642PubMedCrossRefGoogle Scholar
  54. 54.
    Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG (2000) Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clin Endocrinol 52:519–524CrossRefGoogle Scholar
  55. 55.
    Bonte A, Schroder W, Denamur E, Querfeld U (2000) Absent pubertal development in a child with chronic renal failure: the case of Frasier syndrome. Nephrol Dial Transplant 15:1688–1690PubMedCrossRefGoogle Scholar
  56. 56.
    Buzi F, Mella P, Pilotta A, Felappi B, Camerino G, Notarangelo LD (2001) Frasier syndrome with childhood-onset renal failure. Horm Res 55:77–80PubMedCrossRefGoogle Scholar
  57. 57.
    Shimoyama H, Nakajima M, Naka H, Park YD, Hori K, Morikawa H, Yoshioka A (2002) A girl with bilateral ovarian tumours: Frasier syndrome. Eur J Pediatr 161:81–83PubMedCrossRefGoogle Scholar
  58. 58.
    Joki-Erkkila MM, Karikoski R, Rantala I, Lenko HL, Visakorpi T, Heinonen PK (2002) Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome. J Pediatr Adolesc Gynecol 15:145–149PubMedCrossRefGoogle Scholar
  59. 59.
    Chak WL, To KF, Cheng YL, Tsui KM, Lo KL, Tong HM, Lai FM, Wong FK, Choi KS, Chau KF, Li CS (2002) Gonadal mosaicism of Frasier syndrome in 3 Chinese siblings with donor splice site mutation of Wilms’ tumour gene. Nephron 91:526–529PubMedCrossRefGoogle Scholar
  60. 60.
    Loirat C, Andre JL, Champigneulle J, Acquaviva C, Chantereau D, Bourquard R, Elion J, Denamur E (2003) WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms’ tumour. Nephrol Dial Transplant 18:823–825PubMedCrossRefGoogle Scholar
  61. 61.
    Tajima T, Sasaki S, Tanaka Y, Kusunoki H, Nagashima T, Nonomura K, Fujieda K (2003) 46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation. Horm Res 60:302–305PubMedCrossRefGoogle Scholar
  62. 62.
    Wang NJ, Song HR, Schanen NC, Litman NL, Frasier SD (2005) Frasier syndrome comes full circle: genetic studies performed in an original patient. J Pediatr 146:843–844PubMedCrossRefGoogle Scholar
  63. 63.
    Bruening W, Bardeesy N, Silverrnan BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J (1992) Germline intronic and exonic mutations in the Wilms’ tumor gene (WT1) affecting urogenital development. Nat Genet 1:144–148PubMedCrossRefGoogle Scholar
  64. 64.
    Konig A, Jakubiezka S, Wieacker P, Schlosser HW, Gessler M (1993) Further evidence that imbalance of WT 1 isoforms may be involved in Denys-Drash syndrome. Hum Mol Genet 2:1967–1968PubMedCrossRefGoogle Scholar
  65. 65.
    Bardeesy N, Zabel B, Schmitt K, Pelletier J (1994) If TI mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21:663–665CrossRefGoogle Scholar
  66. 66.
    Denamur E, Bocquet N, Mougenot B, Silva FD, Martinat L, Loirat C, Elion J, Bensman A, Ronco P (1999) Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol 10:2219–2223PubMedGoogle Scholar
  67. 67.
    Kinberg JA, Angle CR, Wilson RB (1987) Nephropathy-gonadal dysgenesis, type 2: renal failure in three siblings with XY dysgenesis in one. Am J Kidney Dis 9:507–510PubMedGoogle Scholar
  68. 68.
    Demmer L, Primack W, Loik V, Brown R, Therville N, McElreavey K (1999) Frasier syndrome: a cause of focal segmental glomerulosclerosis in a 46,XX female. J Am Soc Nephrol 10:2215–2218PubMedGoogle Scholar
  69. 69.
    Denamur E, Bocquet N, Baudouin V, Silva FD, Veitia R, Peuchmaur M, Elion J, Gubler MC, Fellous M, Niaudet P, Loirat C (2000) WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int 57:1868–1872PubMedCrossRefGoogle Scholar
  70. 70.
    Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bogdanovic R, Seeman T, Hoppe B, Hildebrandt F, Members of the APN Study Group (2006) Mutations in the Wilms’ tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59:325–331PubMedCrossRefGoogle Scholar
  71. 71.
    Mrowka C, Schedl A (2000) Wilms’ tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol 11:S106–S115PubMedGoogle Scholar
  72. 72.
    Zirn B, Wittmann S, Gessler M (2005) Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy. Am J Kidney Dis 45:1100–1104PubMedCrossRefGoogle Scholar
  73. 73.
    Breslow N, Takashima JR, Ritchey ML, Strong LC, Green DM (2000) Renal failure in the Denys-Drash and Wilms’ tumor-aniridia syndromes. Cancer Res 60:430–432Google Scholar
  74. 74.
    Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM (2005) End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States renal data system. J Urol 174:1972–1975PubMedCrossRefGoogle Scholar
  75. 75.
    Turleau C, de Grouchy J, Tournade MF, Gagnadoux MF, Junien C (1984) Del 11p/aniridia complex. Report of three patients and review of 37 observations from the literature. Clin Genet 26:356–362PubMedCrossRefGoogle Scholar
  76. 76.
    Guo JK, Menke AL, Gubler MC, Clarke AR, Harrison D, Hammes A, Hastie ND, Schedl A (2002) WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 11:651–659PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  1. 1.Service de Néphrologie Pédiatrique and INSERM U574Hôpital Necker-Enfants MaladesParisFrance

Personalised recommendations